Invention Grant
- Patent Title: Aryl aniline β2 adrenergic receptor agonists
-
Application No.: US10642926Application Date: 2003-08-18
-
Publication No.: US06949568B2Publication Date: 2005-09-27
- Inventor: Edmund J. Moran , John R. Jacobsen , James Aggen
- Applicant: Edmund J. Moran , John R. Jacobsen , James Aggen
- Applicant Address: US CA South San Francisco
- Assignee: Theravance, Inc.
- Current Assignee: Theravance, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Roberta P. Saxon; Jeffrey A. Hagenah
- Main IPC: A61P43/00
- IPC: A61P43/00 ; C07C215/60 ; C07C217/84 ; C07C229/38 ; C07C233/43 ; C07D213/75 ; C07D215/22 ; C07D215/227 ; C07D215/26 ; C07D231/22 ; C07D239/38 ; C07D239/42 ; C07D239/46 ; C07D277/46 ; C07D311/80 ; C07D319/08 ; C07D321/10 ; C07D401/12 ; C07D409/12 ; C07D413/12 ; A61K31/47 ; C07D215/16
Abstract:
The invention provides novel β2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
Public/Granted literature
- US20040059116A1 Aryl aniline beta2 adrenergic receptor agonists Public/Granted day:2004-03-25
Information query
